Biotech

All Articles

Viridian eye condition phase 3 hits, accelerating push to rival Amgen

.Viridian Therapeutics' phase 3 thyroid eye health condition (TED) clinical test has attacked its ke...

Bain introduces $3B fund forever science firms

.Along with a tough track record for pinpointing rough diamonds, Bain Financing Everyday Life Scienc...

Genentech's cancer cells restructure brought in 'for clinical factors'

.The latest choice to combine Genentech's two cancer cells teams was actually made for "clinical mai...

Tern dental GLP-1 shows 5% weight reduction at 1 month at greatest dosage

.Terns Pharmaceuticals' selection to fall its own liver condition aspirations may yet repay, after t...

Merck, Daiichi loyal very early effectiveness in tiny cell lung cancer with updated ADC records

.Merck &amp Co.'s long-running initiative to land a strike on small tissue bronchi cancer cells (SCL...

Boehringer, Bayer advance lung cancer cells medicines toward Astra battle

.Some people along with non-small tissue bronchi cancer (NSCLC) have mutations in a genetics referre...

MBX aims for $136M IPO to take opponent to Ascendis into phase 3

.MBX has expanded plans to absorb over $136 million from its own IPO as the biotech aims to deliver ...

Relay bosom cancer cells data tee up clash with AstraZeneca's Truqap

.Relay Rehabs has beaten its own survival objective in a first-in-human bosom cancer research, posit...

AZ outlines AI-enabled TROP2 biomarker method for Daiichi ADC

.AstraZeneca has utilized artificial intelligence to devise an unique biomarker for its own Daiichi ...

AstraZeneca IL-33 medicine neglects to enhance COPD breathing in ph. 2

.AstraZeneca managers say they are "certainly not anxious" that the failing of tozorakimab in a peri...